Langerhans cell histiocytosis following childhood acute lymphoblastic leukemia | Zendy

Raj Ashok | Zendy; Bendon Robert | Zendy; Moriarty Thomas | Zendy; Suarez Carlos | Zendy; Bertolone Salvatore | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Premium

Langerhans cell histiocytosis following childhood acute lymphoblastic leukemia

Author(s) -

Raj Ashok,

Bendon Robert,

Moriarty Thomas,

Suarez Carlos,

Bertolone Salvatore

Publication year - 2001

Publication title -

american journal of hematology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.456

H-Index - 105

eISSN - 1096-8652

pISSN - 0361-8609

DOI - 10.1002/ajh.10004

Subject(s) - langerhans cell histiocytosis , medicine , etiology , chemotherapy , histiocytosis , leukemia , lymphoblastic leukemia , pediatrics , pathology , oncology , immunology , disease

Langerhans cell histiocytosis (LCH) is a clonal proliferation of Langerhans cells of unknown etiology that results in a range of clinical manifestations. LCH has been known to be associated with a variety of malignant diseases. A 7‐year‐old boy was treated for standard‐risk acute lymphoblastic leukemia (ALL) at age 2 years, on a Children's Cancer Group chemotherapy protocol for 3 years and developed LCH 2 years after completion of chemotherapy. The case and a review of literature on the association of LCH and ALL are presented. Am. J. Hematol. 68:284–286, 2001. © 2001 Wiley‐Liss, Inc.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here

Accelerating Research